Document Detail


Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence.
MedLine Citation:
PMID:  21208168     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Abuse of amphetamine-type stimulants (ATS), including amphetamine, methamphetamine (METH), and 3,4-methylenedioxymethamphetamine (MDMA; ecstasy), has become a major public health problem worldwide. Use of these stimulants has significant psychiatric and medical consequences, including psychosis, dependence, overdose, and death. METH abuse in particular is an extremely serious and growing problem in many countries. The development of treatments for METH-related problems is particularly critical for users who experience persistent psychosis, pregnant women and women with children, gay and bisexual men, and users involved in the criminal justice system. However, there are currently no pharmacological treatments for the wide range of symptoms associated with METH-related problems. One of the reasons for this problem is that our knowledge of the cellular and molecular mechanisms underlying the development of METH-induced psychosis and dependence is limited. In this article, we review recent reports on potential pharmacotherapies (naltrexone, minocycline, antioxidants, immunotherapy, and dopaminergic, serotonergic, cholinergic, and GABAergic agents) for the treatment of ATS abusers.
Authors:
Hongxian Chen; Jin Wu; Jichun Zhang; Kenji Hashimoto
Related Documents :
7903968 - Self-assembly of symbionin, a chaperonin of intracellular symbiont.
9051908 - Argenteanones c-e and argenteanols b-e, cytotoxic cycloartanes from aglaia argentea.
20461958 - Clinical case report: a multidisciplinary solution to a complex restorative problem and...
11218478 - The occlusal management of maxillary anterior single-unit implant-supported restorations.
15644068 - Patterns of psychological problems in parkinson's disease.
10976498 - Expectations about hearing aids and their relationship to fitting outcome.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current drug abuse reviews     Volume:  3     ISSN:  1874-4745     ISO Abbreviation:  Curr Drug Abuse Rev     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-02-11     Completed Date:  2011-06-13     Revised Date:  2012-05-07    
Medline Journal Info:
Nlm Unique ID:  101468123     Medline TA:  Curr Drug Abuse Rev     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  222-38     Citation Subset:  IM    
Affiliation:
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amphetamine-Related Disorders / drug therapy*
Antioxidants / therapeutic use*
Clinical Trials as Topic
Humans
Immunotherapy / methods*
Molecular Structure
Psychotropic Drugs / therapeutic use*
Synaptic Transmission / drug effects
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Psychotropic Drugs

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-b...
Next Document:  Behavioral and neurochemical studies in distinct animal models of ethanol's motivational effects.